52 related articles for article (PubMed ID: 36581220)
1. Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family.
Staal J; Driege Y; Van Gaever F; Steels J; Beyaert R
FEBS J; 2024 Mar; 291(6):1220-1245. PubMed ID: 38098267
[TBL] [Abstract][Full Text] [Related]
2. Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB.
Ganguly N; Das T; Bhuniya A; Guha I; Chakravarti M; Dhar S; Sarkar A; Bera S; Dhar J; Dasgupta S; Saha A; Ghosh T; Das J; Sk UH; Banerjee S; Laskar S; Bose A; Baral R
Cell Commun Signal; 2024 Apr; 22(1):237. PubMed ID: 38649988
[TBL] [Abstract][Full Text] [Related]
3. Role of CARD9 in Cell- and Organ-Specific Immune Responses in Various Infections.
Lee JS; Kim C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473845
[TBL] [Abstract][Full Text] [Related]
4. Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.
Hargadon KM
Front Immunol; 2017; 8():1594. PubMed ID: 29209327
[TBL] [Abstract][Full Text] [Related]
5. Translational genetics identifies a phosphorylation switch in CARD9 required for innate inflammatory responses.
Brandt M; Cao Z; Krishna C; Reedy JL; Gu X; Dutko RA; Oliver BA; Tusi BK; Park J; Richey L; Segerstolpe Å; Litwiler S; Creasey EA; Carey KL; Vyas JM; Graham DB; Xavier RJ
Cell Rep; 2024 Mar; 43(3):113944. PubMed ID: 38489265
[TBL] [Abstract][Full Text] [Related]
6. BUB1 Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Inhibiting Ferroptosis.
Wang W; Zhou X; Kong L; Pan Z; Chen G
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672622
[TBL] [Abstract][Full Text] [Related]
7. Unlocking the power of immunotherapy: Combinatorial delivery of plasmid IL-15 and gemcitabine to synergistically remodeling the tumor microenvironment.
Liu J; Han Y; Zhao M; Wang L; Hu H; Chen D
Int J Pharm; 2024 Apr; 655():124027. PubMed ID: 38554742
[TBL] [Abstract][Full Text] [Related]
8. PIKfyve controls dendritic cell function and tumor immunity.
Choi JE; Qiao Y; Kryczek I; Yu J; Gurkan J; Bao Y; Gondal M; Tien JC; Maj T; Yazdani S; Parolia A; Xia H; Zhou J; Wei S; Grove S; Vatan L; Lin H; Li G; Zheng Y; Zhang Y; Cao X; Su F; Wang R; He T; Cieslik M; Green MD; Zou W; Chinnaiyan AM
bioRxiv; 2024 Mar; ():. PubMed ID: 38464258
[TBL] [Abstract][Full Text] [Related]
9. Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer.
Husain K; Villalobos-Ayala K; Laverde V; Vazquez OA; Miller B; Kazim S; Blanck G; Hibbs ML; Krystal G; Elhussin I; Mori J; Yates C; Ghansah T
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892872
[TBL] [Abstract][Full Text] [Related]
10. Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer.
Ray P; Nair G; Ghosh A; Banerjee S; Golovko MY; Banerjee SK; Reindl KM; Mallik S; Quadir M
J Cell Commun Signal; 2019 Sep; 13(3):407-420. PubMed ID: 30915617
[TBL] [Abstract][Full Text] [Related]
11. The Potential of Korean Bioactive Substances and Functional Foods for Immune Enhancement.
Kim ME; Lee JS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279334
[TBL] [Abstract][Full Text] [Related]
12. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.
Amiri M; Molavi O; Sabetkam S; Jafari S; Montazersaheb S
Cancer Cell Int; 2023 Sep; 23(1):200. PubMed ID: 37705051
[TBL] [Abstract][Full Text] [Related]
13. A
De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
Front Immunol; 2018; 9():2366. PubMed ID: 30429846
[No Abstract] [Full Text] [Related]
14. CARD9 deficiency promotes pancreatic cancer growth by blocking dendritic cell maturation via SLC6A8-mediated creatine transport.
Tian C; Yuan H; Lu Y; He H; Li Q; Li S; Yang J; Wang M; Xu R; Liu Q; Xiang M
Oncoimmunology; 2023; 12(1):2204015. PubMed ID: 37089447
[TBL] [Abstract][Full Text] [Related]
15. The signaling relations between three adaptors of porcine C-type lectin receptor pathway.
Jiang S; Ao D; Ni J; Chen N; Meurens F; Zhu J
Dev Comp Immunol; 2020 Mar; 104():103555. PubMed ID: 31751629
[TBL] [Abstract][Full Text] [Related]
16. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.
Pérez de Diego R; Sánchez-Ramón S; López-Collazo E; Martínez-Barricarte R; Cubillos-Zapata C; Ferreira Cerdán A; Casanova JL; Puel A
J Allergy Clin Immunol; 2015 Nov; 136(5):1139-49. PubMed ID: 26277595
[TBL] [Abstract][Full Text] [Related]
17. Regulatory roles of CARD9-BCL10-Rac1 (CBR) signalome in islet β-cell function in health and metabolic stress: Is there room for MALT1?
Kowluru A
Biochem Pharmacol; 2023 Dec; 218():115889. PubMed ID: 37991197
[TBL] [Abstract][Full Text] [Related]
18. The combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway.
Li Q; He J; Li S; Tian C; Yang J; Yuan H; Lu Y; Fagone P; Nicoletti F; Xiang M
Clin Immunol; 2023 Mar; 248():109217. PubMed ID: 36581220
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
